CPG10101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CPG10101, covering 2011-05-16 to 2017-03-08. Get the full timeline:
Most recent: Clinical Trial Update: CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects [Phase 2]